Patent details

EP2114367 Title: OLOPATADINE FORMULATIONS FOR TOPICAL NASAL ADMINISTRATION

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2114367
WO Application Number:
US2007003285
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP07750153.4
WO Publication Number:
WO2008097220
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
07/02/2007
Grant date:
04/11/2015
EP Publication Date:
11/11/2009
WO Publication Date:
14/08/2008
Claims Translations Received Date:
Claims Translation B1 Received Date:
16/12/2015
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
04/11/2015
EP B1 Publication Date:
04/11/2015
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
06/02/2027
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
01/09/2020
 
 

 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Historical Applicant/holder

From:
01/09/2020
To:
01/09/2020

 

Name:
Alcon Pharmaceuticals Ltd.
Address:
Rue Louis-d'Affry 6, 1701, Fribourg, Switzerland (CH)

From:
04/11/2015
To:
01/09/2020

 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 BASEL, Switzerland (CH)

Domicile Holder

Name:
J.M.H. Duyver lic.
From:
18/02/2016
Address:
Gevers Patents De Kleetlaan 7A, B-1831, Diegem, Belgium (BE)
To:

Inventor

1

Name:
SINGH, Onkar, N.
Address:
Arlington, TX 76017, United States of America (US)

2

Name:
WALL, G., Michael
Address:
Forth Worth, TX 76109, United States of America (US)

3

Name:
JANI, Rajni
Address:
Fort Worth, TX 76109, United States of America (US)

4

Name:
CHOWHAN, Masood, A.
Address:
Arlington, TX 76016, United States of America (US)

5

Name:
HAN, Wesley, Wehsin
Address:
Arlington, TX 76006, United States of America (US)

Classification

IPC or IDT classification:
A61K 9/00; A61K 31/335;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
38/20
Publication date:
16/09/2020
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
CO
Journal edition number:
38/20
Publication date:
16/09/2020
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
EP3
Journal edition number:
08/16
Publication date:
24/02/2016
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

4

Bulletin Heading:
EP2
Journal edition number:
47/15
Publication date:
19/11/2015
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201545
Publication date:
04/11/2015
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202001700A
Date Registered:
01/09/2020
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Alcon Pharmaceuticals Ltd.
Address:
Rue Louis-d'Affry 6, 1701, Fribourg, Switzerland (CH)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202001700B
Date Registered:
01/09/2020
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
28/01/2026
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
1400 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
18/02/2016 Outgoing Correspondence Outgoing Letter 1 PDF /8/7/5/2/1/0800012578/docs/ep07750153.4_1_35634l271.pdf
16/12/2015 Claims Translated claims 2 PDF /8/7/5/2/1/0800012578/docs/ep07750153.4_0_claims20151216151124113.pdf
16/12/2015 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /8/7/5/2/1/0800012578/docs/ep07750153.4_2_incomingcorrespondenceelectronic20151216151124616.pdf
16/12/2015 Outgoing Correspondence Outgoing Letter 1 PDF /8/7/5/2/1/0800012578/docs/ep07750153.4_3_outgoingcorrespondence20151216151123514.pdf